Has Thomas Leavens received payments from drug or device companies?

Yes. Drug and device makers reported $7,717 in general payments to Thomas Leavens across 320 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Leavens did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Leavens come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Leavens

Neurology · Fort Worth, TXNPI 1114910460

Payments from drug & device makers

$7,717in general payments, 2019–2025

Across 320 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$854
Amgen$594
UCB, Inc.$528
AstraZeneca$425
Novartis$423
Biogen$413
plus $4K from 42 others

What the payments were for

Speaking & faculty fees$1392%
Travel & lodging$50%
Food & beverage$7,56898%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	42	$854
Amgen	14	$594
UCB, Inc.	23	$528
AstraZeneca	8	$425
Novartis	17	$423
Biogen	13	$413
Sanofi	12	$395
Lilly USA, LLC	14	$332
EMD Serono, Inc.	15	$300
AbbVie(2 entities)	15	$299
Amneal Pharmaceuticals LLC	9	$252
Jazz Pharmaceuticals Inc.	8	$250
Genentech USA, Inc.	10	$218
Greenwich Biosciences, Inc.	5	$206
SK Life Science, Inc.	5	$202
Grifols USA, LLC	16	$201
Merz Pharmaceuticals, LLC	7	$178
Lundbeck LLC	9	$177
Acorda Therapeutics, Inc	8	$175
Supernus Pharmaceuticals, Inc.	7	$118
Adamas Pharmaceuticals, Inc.	6	$112
Kyowa Kirin, Inc.	4	$91
Merz North America, Inc.	3	$78
Akcea Therapeutics, Inc.	1	$61
Pfizer	4	$55
Mallinckrodt Enterprises LLC	2	$54
Aquestive Therapeutics, Inc.	3	$54
Eisai Inc.	3	$53
Avanir Pharmaceuticals, Inc.	3	$45
Portola Pharmaceuticals, LLC	2	$45
Neurocrine Biosciences, Inc.	2	$44
Arbor Pharmaceuticals, Inc.	3	$44
Zyla Life Sciences, Inc.	3	$44
Upsher-smith Laboratories LLC	2	$40
Alnylam Pharmaceuticals Inc.	2	$33
Biohaven Pharmaceuticals, Inc.	2	$32
Bristol Myers Squibb	2	$32
GE HealthCare	2	$32
Vertical Pharmaceuticals, LLC	2	$29
CSL Behring	1	$28
Harmony Biosciences LLC	2	$27
Assertio Therapeutics, Inc.	2	$27
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Acadia Pharmaceuticals Inc	1	$21
Sunovion Pharmaceuticals Inc.	2	$20
Almatica Pharma LLC	1	$18
Medtronic	1	$17
Promius Pharma LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,717 in reported general payments places this provider in the 60th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Other neurology in Fort Worth

Horacio Chiong-RiveroFort Worth$696K
Ann BassSan Antonio$12.3M
Kandasami SenthilkumarBeaumont$7.6M
Bharathy SundaramSherman$7.2M
Bhupesh DiheniaLubbock$6.9M
Jamshid LotfiHouston$6M
Nazanin MajdHouston$5.9M
Aziz ShaibaniHouston$5.5M
Elizabeth PeckhamRound Rock$5.4M
Susan IannacconeDallas$5.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →